Streamlining Cancer Biomarker Detection for Point-of-Care Diagnostics with microRNAs
The detection and quantification of cancer-associated molecular biomarkers in body fluids prove minimally invasive in early cancer diagnostics.
Read MorePosted by Andy Lundin | Jan 31, 2022 | Cancer, Point-of-Care |
The detection and quantification of cancer-associated molecular biomarkers in body fluids prove minimally invasive in early cancer diagnostics.
Read MorePosted by Andy Lundin | Jan 4, 2022 | Company News, Immunoassay Reagents & test Kits, POC Reagents & Test Kits |
The acquisition is expected to streamline the commercialization of the company’s Eikon platform and YourTest PCR device as it nears completion.
Read MorePosted by Andy Lundin | Dec 23, 2021 | Company News, POC Reagents & Test Kits |
The company expects that the acquisition will streamline the commercialization of the Eikon platform and YourTest PCR device as it nears completion.
Read MorePosted by Chris Wolski | Sep 20, 2021 | POC Instruments, POC Rapid Assays, POC Reagents & Test Kits |
The Tech Guide from the September 2021 issue of Clinical Lab Products includes point-of-care assays and analyzers from 17 suppliers.
Read MorePosted by Chris Wolski | Jun 18, 2021 | Point-of-Care |
DCN Dx, an international provider of point-of-care diagnostics development, has announced completing its acquisition of PortaScience, Inc.
Read More